Environment &
Food & Beverage
Cosmetics
Life Sciences
Metal & Mining Industry
Petrochemical & General Chemistry
Automotive Related & Interior Materials
InertSearch (Application Library)
Index
Application
LC
Micro GC
Document No. Index
LC001 - 053 of Application List
| No. | Description | Column |
|---|---|---|
| LC001 | Analysis of Sugar alcohols | InertSphere Sugar-1 |
| LC002 | Analysis of Phenazopyridine hydrochloride | InertSustain C18 |
| LC003 | Analysis of Urea and Thiourea | InertSustain Amide |
| LC004 | Analysis of Urea and Thiourea | InertSustain AQ-C18 |
| LC005 | Carbamazepine | InertSustainSwift C18 |
| LC006 | Analysis of Benzoyl Peroxide（Under the Condition of food additive analysis method in food, Benzoyl peroxide) | Inertsil ODS-3 |
| LC007 | Analysis of Olanzapine | InertSustain C8 |
| LC008 | Analysis of Ketotifen Fumarate (Under the Condition of USP-NF 2024 Issue 3, Ketotifen Fumarate, ASSAY) | InertSustain C18 |
| LC009 | Analysis of Ketotifen Fumarate (Under the Condition of USP-NF 2024 Issue 3, Ketotifen Fumarate, ASSAY) | Inertsil ODS-3 |
| LC010 | Analysis of Imazalil (Under the Condition of food additive analysis method in food, Imazalil) | Inertsil ODS-3 |
| LC011 | Analysis of Spectinomycin | InertSustain C8 |
| LC012 | Analysis of Ethanol and Acetonitrile (Under the Condition for the Draft for USP, Tavaborole Topical Solution, Content of Alcohol) | Inertsil NH2 |
| LC013 | Analysis of Bleomycin sulfate | InertSustain AQ-C18 |
| LC014 | Analysis of Itraconazole (Under the Condition of USP43-NF38, Itraconazole, ASSAY) | InertSustainSwift C18 |
| LC015 | Analysis of Itraconazole (Under the draft for USP, Itraconazole Oral Solution, ASSAY) | InertSustain C18 |
| LC016 | Analysis of Itraconazole (Under the Condition of USP-NF 2021 Issue 2, Itraconazole Capsules, ASSAY) | InertSustain C18 |
| LC017 | Analysis of Itraconazole (Under the Condition of Japanese Pharmacopoeia 18th, Itraconazole, Purity(2) Related substances) | InertSustain C18 |
| LC018 | Analysis of L-α-Aspartyl-D-phenylalanine Methyl Ester (Japan’s Standards and Specifications for Food Additives (10th ed.), Aspartame, Purity(5)) | InertSustain C18 |
| LC019 | Analysis of Aspartame and L-α-Aspartyl-D-phenylalanine Methyl Ester | InertSustain C18 |
| LC020 | Analysis of D(-)-Mannitol | InertSphere FA-1 |
| LC021 | Analysis of Cyanocobalamin (Under the Condition of USP4１-NF3６, Oil- and Water-Soluble Vitamins Capsules,Cyanocobalamin_Method1) | Inertsil ODS-HL |
| LC022 | Analysis of Ursodeoxycholic acid (Under the Condition of the Japanese Pharmacopoeia 18th, Ursodeoxycholic acid Tablets, Ursodeoxycholic acid Granules) | InertSustain C18 |
| LC023 | Analysis of Lansoprazole (Under the Condition of the USP41-NF36, Lansoprazole Compounded Oral Suspension, ASSAY) | InertSustain C18 |
| LC024 | Analysis of Eplerenone (Under the Condition of draft for USP, Eplerenone, ASSAY) | Inertsil ODS-3 |
| LC025 | Analysis of Eplerenone (Under the Condition of draft for USP, Eplerenone Tablets, ASSAY) | InertSustain AQ-C18 |
| LC026 | Analysis of Nicotinic acid (Under the Condition of USP41-NF36, Oil- and Water-Soluble Vitamins Capsules,Niacin_Method 2) | InertSustain C18 |
| LC027 | Analysis of Nicotinamide (Under the Condition of USP41-NF36, Oil- and Water-Soluble Vitamins Capsules,NIACINAMIDE_Method 2) | InertSustain C18 |
| LC028 | Analysis of Pyridoxine hydrochloride (Under the Condition of USP41-NF36, Oil- and Water-Soluble Vitamins Capsules,PYRIDOXINE HYDROCHLORIDE_Method 2) | InertSustain C18 |
| LC029 | Analysis of Riboflavin (Under the Condition of USP41-NF36, Oil- and Water-Soluble Vitamins Capsules,RIBOFLAVIN_Method 2) | InertSustain C18 |
| LC030 | Analysis of Piperazine anhydrous | InertSustain Amide |
| LC031 | Analysis of D‐Biotin (Under the Condition of USP43-NF38, Biotin) | InertSustain C8 |
| LC032 | Analysis of D‐Biotin (Under the Condition of USP4１-NF3６, Oil- and Water-Soluble Vitamins Capsules,BIOTIN_Method 1) | InertSustain C8 |
| LC033 | Analysis of D‐Biotin (Under the Condition of USP43-NF38, Oil- and Water-Soluble Vitamins Minerals Tablets,BIOTIN_Method 3) | InertSustain C18 |
| LC034 | Analysis of Zonisamide (Under the Condition of USP43-NF38, Zonisamide, ASSAY) | InertSustain C18 |
| LC035 | Analysis of Zonisamide (Under the Condition of USP43-NF38, Zonisamide Capsules, ASSAY) | InertSustain C18 |
| LC036 | Analysis of Zonisamide (Under the Condition of USP41-NF36, Zonisamide Compounded Oral Suspension, ASSAY) | InertSustain C18 |
| LC037 | Analysis of Amlodipine Besilate (Under the Condition of the Japanese Pharmacopoeia 18th, Amlodipine Besilate, Purity(2) Related Substances) | InertSustain C18 |
| LC038 | Analysis of Brilliant Green and Methylene Blue | InertSustain C18 |
| LC039 | Analysis of Acetaminophen (Under the Condition of the USPNF2023 Issue 1, Acetaminophen, ASSAY) | InertSustainSwift C8 |
| LC040 | Analysis of Acetaminophen (Under the Condition of the USPNF2023 Issue 1, Acetaminophen, IMPURITIES, Limit of Free 4-Aminophenol) | InertSustainSwift C8 |
| LC041 | Analysis of Nicotinamide,Pyridoxine Hydrochloride,Riboflavin,and Thiamine hydrochloride_Method1 (Under the Condition of USP41-NF36, Oil- and Water-Soluble Vitamins Capsules,Niacin or Niacinamide,Pyridoxine Hydrochloride,Riboflavin,and Thiamine_ Method1) | InertSustain C18 |
| LC042 | Analysis of Nicotinic acid,Pyridoxine Hydrochloride,Riboflavin,and Thiamine hydrochloride_Method3 (Under the Condition of USP41-NF36, Oil- and Water-Soluble Vitamins Capsules,Niacin or Niacinamide,Pyridoxine Hydrochloride,Riboflavin,and Thiamine_ Method3) | InertSustain C8 |
| LC043 | Analysis of Semaglutide and Tirzepatide | InertSustainSwift C18 |
| LC044 | Analysis of Calcium Pantothenate (Under the Condition of USP4１-NF3６, Oil- and Water-Soluble Vitamins Capsules,Calcium Pantothenate, Method1) | InertSustainSwift C18 |
| LC045 | Analysis of Catecholamines | Inertsil ODS-4 |
| LC046 | Analysis of Sugars | InertSphere Sugar-2 |
| LC047 | Analysis of Homocysteine | InertSustain AQ-C18 |
| LC048 | Analysis of Homocysteine | InertSustain Phenyl |
| LC049 | Analysis of Vitamin E (Under the Condition of USP41-NF36, Oil- and Water-Soluble Vitamins Capsules,Vitamin E_Method 2) | InertSustain C18 |
| LC050 | Analysis of Vitamin E (Under the Condition of USP41-NF36, Oil- and Water-Soluble Vitamins Capsules,Vitamin E_Method 3) | Inertsil WP300 C18 |
| LC051 | Analysis of Vitamin C (Under the Condition of USP41-NF36, Vitamin C ASSAY,PROCEDURE 1) | InertSustain AQ-C18 |
| LC052 | Analysis of Vitamin C (Under the Condition of USP41-NF36, Vitamin C ASSAY,PROCEDURE 2) | InertSustain C8 |
| LC053 | Analysis of Folic acid (Under the Condition of USP41-NF36, Oil- and Water-Soluble Vitamins Capsules,FOLIC ACID_Method 2) | InertSustain C8 |